Amlodipine 5 mg

DRUG6 trials

Sponsors

Boehringer Ingelheim, Novartis, Novartis Pharmaceuticals, GlaxoSmithKline, Italo Biaggioni

Conditions

Essential HypertensionHypertensionObesity-Associated Insulin Resistance

Phase 1

A Fixed Dose Combination Amlodipine + Enalapril Bioavailability Study

CompletedNCT01822639

GlaxoSmithKlineHypertension

Start: 2013-04-03End: 2013-05-24Updated: 2017-06-05

Sympathetic Mechanisms in the Cardiovascular and Metabolic Alterations of Obesity

TerminatedNCT04329806

Italo BiaggioniObesity-Associated Insulin Resistance

Start: 2021-02-23End: 2022-07-27Updated: 2025-09-05

Phase 2

Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension

CompletedNCT00425373

Novartis PharmaceuticalsEssential Hypertension

Start: 2006-11-30End: 2008-03-31Updated: 2011-04-29

Phase 3

Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension

CompletedNCT00281580

Boehringer IngelheimHypertension

Start: 2006-04-30Updated: 2014-03-27

Efficacy/Safety of Valsartan Plus Amlodipine and Amlodipine Alone in Patients With Hypertension

CompletedNCT00413049

NovartisHypertension

Start: 2007-01-31End: 2007-11-30Updated: 2011-04-29

Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension

CompletedNCT00699192

Novartis PharmaceuticalsHypertension

Start: 2008-05-31End: 2009-05-31Updated: 2011-06-06

Related Papers

Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study

Drug Design Development and Therapy2020-12-0125 citations

Efficacy and safety of a single-pill combination of amlodipine/valsartan in Asian hypertensive patients inadequately controlled with amlodipine monotherapy.

2010-07-0125 citations